Cystatin C in cerebrospinal fluid and multiple sclerosis

Ann Neurol. 2007 Aug;62(2):193-6; discussion 205. doi: 10.1002/ana.20945.

Abstract

Objective: A recent study using surface-enhanced laser desorption/ionization time-of-flight analysis of cerebrospinal fluid identified a 12.5 kDa truncated isoform of cystatin C (CysC) as a specific biomarker for multiple sclerosis (MS).

Methods: Surface-enhanced laser desorption/ionization time-of-flight analysis of cerebrospinal fluid samples from 43 MS patients and 46 healthy control subjects.

Results: Full-length CysC (13.4 kDa) concentration was similar in MS and control samples. The 12.5 kDa CysC protein was produced from full-length CysC by N-terminal cleavage during storage at -20 degrees C.

Interpretation: The 12.5 kDa CysC isoform is a storage-related artifact and is not useful as a diagnostic marker for MS.

Publication types

  • Research Support, Non-U.S. Gov't
  • Validation Study

MeSH terms

  • Amino Acid Sequence
  • Artifacts
  • Biomarkers / cerebrospinal fluid
  • Cystatin C
  • Cystatins / cerebrospinal fluid*
  • Cystatins / chemistry
  • Cystatins / genetics
  • Drug Storage
  • Freezing
  • Humans
  • Molecular Weight
  • Multiple Sclerosis / cerebrospinal fluid*
  • Osmolar Concentration
  • Peptide Fragments / cerebrospinal fluid
  • Peptide Fragments / chemistry
  • Peptide Fragments / genetics
  • Protein Isoforms / cerebrospinal fluid
  • Protein Isoforms / chemistry
  • Protein Isoforms / genetics
  • Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
  • Time Factors

Substances

  • Biomarkers
  • CST3 protein, human
  • Cystatin C
  • Cystatins
  • Peptide Fragments
  • Protein Isoforms